bnt162b2 ba.4 Search Results


bnt162b2 bivalent (wt/omi ba.4/ba.5)  (Pfizer Inc)
90
Pfizer Inc bnt162b2 bivalent (wt/omi ba.4/ba.5)
Bnt162b2 Bivalent (Wt/Omi Ba.4/Ba.5), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 bivalent (wt/omi ba.4/ba.5)/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
bnt162b2 bivalent (wt/omi ba.4/ba.5) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bnt162b2 bivalent (ancestral strain/ omicron ba.4/ba.5)  (BioNTech)
90
BioNTech bnt162b2 bivalent (ancestral strain/ omicron ba.4/ba.5)
Combination of currently available heterologous vaccines.
Bnt162b2 Bivalent (Ancestral Strain/ Omicron Ba.4/Ba.5), supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bnt162b2 bivalent (ancestral strain/ omicron ba.4/ba.5)/product/BioNTech
Average 90 stars, based on 1 article reviews
bnt162b2 bivalent (ancestral strain/ omicron ba.4/ba.5) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Combination of currently available heterologous vaccines.

Journal: NPJ Vaccines

Article Title: Challenges and developments in universal vaccine design against SARS-CoV-2 variants

doi: 10.1038/s41541-022-00597-4

Figure Lengend Snippet: Combination of currently available heterologous vaccines.

Article Snippet: BNT162b2 (ancestral strain), BNT162b5 Bivalent (ancestral strain/ Omicron BA.2), BNT162b2 Bivalent (ancestral strain/ Omicron BA.1), BNT162b2 Bivalent (ancestral strain/ Omicron BA.4/BA.5) , Pfizer-BioNTech , Phase 2/3 or completed; an interventional randomized, active-controlled study to investigate the safety and immunogenicity of bivalent BNT162b RNA-based vaccine candidates as a booster dose , Prime: BNT162b2; Boost: BNT162b5 Bivalent/ BNT162b2 Bivalent (WT/OMI BA.1)/ BNT162b2 Bivalent (WT/OMI BA.4/BA.5) , NCT05472038.

Techniques: Infection, Variant Assay, Recombinant, Neutralization

Variant-targeting booster vaccines.

Journal: NPJ Vaccines

Article Title: Challenges and developments in universal vaccine design against SARS-CoV-2 variants

doi: 10.1038/s41541-022-00597-4

Figure Lengend Snippet: Variant-targeting booster vaccines.

Article Snippet: BNT162b2 (ancestral strain), BNT162b5 Bivalent (ancestral strain/ Omicron BA.2), BNT162b2 Bivalent (ancestral strain/ Omicron BA.1), BNT162b2 Bivalent (ancestral strain/ Omicron BA.4/BA.5) , Pfizer-BioNTech , Phase 2/3 or completed; an interventional randomized, active-controlled study to investigate the safety and immunogenicity of bivalent BNT162b RNA-based vaccine candidates as a booster dose , Prime: BNT162b2; Boost: BNT162b5 Bivalent/ BNT162b2 Bivalent (WT/OMI BA.1)/ BNT162b2 Bivalent (WT/OMI BA.4/BA.5) , NCT05472038.

Techniques: Variant Assay, Recombinant